This Article Full Text Full Text (PDF) All Versions of this Article: 46/4/1046    most recent 01.HYP.0000172622.51973.f5v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ishizawa, K. Articles by Yoshizumi, M. Search for Related Content PubMed PubMed Citation Articles by Ishizawa, K. Articles by Yoshizumi, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CYCLOHEXIMIDE SPIRONOLACTONE Related Collections Remodeling Cell signalling/signal transduction Hypertension - basic studies Smooth muscle proliferation and differentiation

(Hypertension. 2005;46:1046.)
© 2005 American Heart Association, Inc.

Part 2 Original Articles

Aldosterone Stimulates Vascular Smooth Muscle Cell Proliferation Via Big Mitogen-Activated Protein Kinase 1 Activation

Keisuke Ishizawa; Yuki Izawa; Hiroyuki Ito; Chieko Miki; Kayoko Miyata; Yoshiko Fujita; Yasuhisa Kanematsu; Koichiro Tsuchiya; Toshiaki Tamaki; Akira Nishiyama; Masanori Yoshizumi

From the Department of Pharmacology (K.I., Y.I., H.I., C.M., Y.F., Y.K., K.T., T.T.), The University of Tokushima Graduate School of Medicine, Japan; RI Research Center (K.M.) and Department of Pharmacology (A.N.), Kagawa Medical University, Japan; and Department of Pharmacology (M.Y.), Nara Medical University School of Medicine, Japan.

Correspondence to Masanori Yoshizumi, MD, PhD, Department of Pharmacology, Nara Medical University School of Medicine, Shijo-cho 840, Kashihara, Nara 634-8521, Japan. E-mail yoshizu{at}naramed-u.ac.jp

The nongenomic effects of aldosterone have been implicated in the pathogenesis of various cardiovascular diseases. Aldosterone-induced nongenomic effects are attributable in part to the activation of extracellular signal-regulated kinase 1/2 (ERK1/2), a classical mitogen-activated protein (MAP) kinase. Big MAP kinase 1 (BMK1), a newly identified MAP kinase, has been shown to be involved in cell proliferation, differentiation, and survival. We examined whether aldosterone stimulates BMK1-mediated proliferation of cultured rat aortic smooth muscle cells (RASMCs). Mineralocorticoid receptor (MR) expression and localization were evaluated by Western blotting analysis and fluorolabeling methods. ERK1/2 and BMK1 activities were measured by Western blotting analysis with the respective phosphospecific antibodies. Cell proliferation was determined by Alamar Blue colorimetric assay. Aldosterone (0.1 to 100 nmol/L) dose-dependently activated BMK1 in RASMCs, with a peak at 30 minutes. To clarify whether aldosterone-induced BMK1 activation is an MR-mediated phenomenon, we examined the effect of eplerenone, a selective MR antagonist, on aldosterone-induced BMK1 activation. Eplerenone (0.1 to 10 µmol/L) dose-dependently inhibited aldosterone-induced BMK1 activation in RASMCs. Aldosterone also stimulated RASMC proliferation, which was inhibited by eplerenone. Aldosterone-mediated phenomena were concluded to be attributable to a nongenomic effect because cycloheximide failed to inhibit aldosterone-induced BMK1 activation. Transfection of dominant-negative MAP kinase/ERK kinase 5 (MEK5), which is an upstream regulator of BMK1, partially inhibited aldosterone-induced RASMC proliferation, which was almost completely inhibited by MEK inhibitor PD98059. In addition to the classical steroid activity, rapid nongenomic effects induced by aldosterone may represent an alternative etiology for vascular diseases such as hypertension.

Key Words: mineralocorticoids • aldosterone • protein kinases

This article has been cited by other articles:

				F. Waanders, H. Rienstra, M. W. Boer, A. Zandvoort, J. Rozing, G. Navis, H. van Goor, and J.-L. Hillebrands Spironolactone ameliorates transplant vasculopathy in renal chronic transplant dysfunction in rats Am J Physiol Renal Physiol, May 1, 2009; 296(5): F1072 - F1079. [Abstract] [Full Text] [PDF]

				J. Goto, F. Otsuka, M. Yamashita, J. Suzuki, H. Otani, H. Takahashi, T. Miyoshi, Y. Mimura, T. Ogura, and H. Makino Enhancement of aldosterone-induced catecholamine production by bone morphogenetic protein-4 through activating Rho and SAPK/JNK pathway in adrenomedullar cells Am J Physiol Endocrinol Metab, April 1, 2009; 296(4): E904 - E916. [Abstract] [Full Text] [PDF]

				H. Otani, F. Otsuka, K. Inagaki, M. Takeda, T. Miyoshi, J. Suzuki, T. Mukai, T. Ogura, and H. Makino Antagonistic effects of bone morphogenetic protein-4 and -7 on renal mesangial cell proliferation induced by aldosterone through MAPK activation Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1513 - F1525. [Abstract] [Full Text] [PDF]